ED:NYSEConsolidated Edison, Inc. Analysis
Data as of 2026-06-17 - not real-time
$108.37
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Consolidated Edison (ED) is trading at $108.37, just above its 20‑day (≈$106.4) and 200‑day (≈$104.3) simple moving averages and marginally above the 50‑day SMA (≈$108.2), indicating a modest short‑term bullish bias. The RSI sits at 55, the MACD histogram is positive and the MACD signal is deemed bullish, while the price is testing a resistance near $109.4 and a support around $102.8, suggesting limited upside momentum. Volatility over the past 30 days is high for a utility at ~18.7% and volume is decreasing, which adds a layer of price uncertainty despite a low beta that points to modest market‑wide risk.
Fundamentally, ED’s trailing PE of ~18.3 is below the industry average of ~20.7, and it offers a solid dividend yield of 3.21% with a payout ratio of 58%, supporting dividend sustainability. However, the company carries a very high debt‑to‑equity ratio (>100) and free cash flow is negative, raising concerns about leverage and cash generation. Recent analyst sentiment has turned cautious, with Morgan Stanley cutting its target to $99 and Mizuho downgrading to Neutral, reflecting limited upside (≈1.3% upside vs downside) despite a fair valuation relative to peers.
Fundamentally, ED’s trailing PE of ~18.3 is below the industry average of ~20.7, and it offers a solid dividend yield of 3.21% with a payout ratio of 58%, supporting dividend sustainability. However, the company carries a very high debt‑to‑equity ratio (>100) and free cash flow is negative, raising concerns about leverage and cash generation. Recent analyst sentiment has turned cautious, with Morgan Stanley cutting its target to $99 and Mizuho downgrading to Neutral, reflecting limited upside (≈1.3% upside vs downside) despite a fair valuation relative to peers.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with limited upside
- Recent analyst downgrades and lower price targets
- Strong dividend yield providing near‑term income
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Stable regulated cash flows offsetting high leverage
- Valuation roughly in line with sector peers
- Continued dividend payments supporting total return
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Long‑term regulated revenue base
- Dividend sustainability despite debt load
- Potential for modest earnings growth balanced by capital‑intensive investments
Key Metrics & Analysis
Financial Health
Revenue Growth6.20%
Profit Margin12.52%
P/E Ratio18.3
ROE8.73%
ROA3.17%
Debt/Equity106.18
P/B Ratio1.6
Op. Cash Flow$4.1B
Free Cash Flow$-833249984
Industry P/E20.7
Technical Analysis
TrendNeutral
RSI55.3
Support$102.82
Resistance$109.42
MA 20$106.41
MA 50$108.21
MA 200$104.31
MACDBullish
VolumeDecreasing
Fear & Greed Index92.16
Valuation
Fair Value$61.86
Target Price$109.75
Upside/Downside1.27%
GradeFair
TypeValue
Dividend Yield3.21%
Risk Assessment
Beta-0.40
Volatility18.71%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.